background
respiratori
viral
atyp
bacteri
infect
data
egyptian
patient
spars
studi
describ
clinic
featur
outcom
patient
sever
acut
respiratori
infect
sari
hospit
patient
egypt
method
sari
surveil
implement
cairo
univers
hospit
cuh
period
hospit
patient
meet
case
definit
sari
enrol
nasopharyngealoropharyng
np
op
swab
collect
sampl
test
use
rtpcr
influenza
b
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
parainfluenza
viru
piv
adenoviru
bocaviru
coronaviru
enteroviru
rhinoviru
atyp
bacteria
data
analyz
calcul
posit
rate
viral
pathogen
determin
pathogen
relat
sever
outcom
result
death
result
overal
case
viral
etiolog
mean
age
year
highest
rate
report
rsv
case
piv
adenoviru
children
higher
viral
rate
compar
case
adult
patient
identifi
virus
significantli
lower
rate
icu
admiss
hospit
stay
mechan
ventil
overal
mortal
without
identifi
virus
infect
independ
associ
sever
outcom
conclus
viral
pathogen
encount
onethird
hospit
adult
pediatr
egyptian
patient
sari
atyp
bacteria
minor
role
highest
rate
viral
infect
report
rsv
piv
adenoviru
viral
infect
neither
neg
impact
clinic
featur
outcom
patient
sari
local
world
health
organ
estim
acut
respiratori
infect
ari
caus
annual
death
approach
million
rate
death
popul
virus
respons
ari
respiratori
syncyti
viru
rsv
influenza
viru
parainfluenza
viru
piv
human
bocaviru
human
metapneumoviru
hmpv
adenoviru
rhinoviru
enteroviru
coronavirus
account
major
case
influenza
pandem
highlight
need
global
data
sever
influenza
diseas
recommend
conduct
surveil
hospit
sever
acut
respiratori
infect
sari
well
influenzalik
ill
ili
outpati
sari
surveil
conduct
mani
countri
around
world
howev
limit
resourc
conduct
limit
set
middl
east
egypt
furthermor
role
individu
viral
atyp
bacteri
infect
caus
ari
usual
document
current
studi
analyz
surveil
data
egyptian
patient
sari
enrol
cairo
univers
hospit
cuh
aim
calcul
proport
posit
sampl
differ
viral
pathogen
determin
pathogen
relat
sever
outcom
address
impact
sari
clinic
outcom
enrol
patient
term
morbid
mortal
cairo
univers
hospit
cuh
tertiari
referr
teach
hospit
inclus
criteria
consist
hospit
adult
defin
age
year
old
well
pediatr
patient
age
year
old
diagnosi
sari
provid
respiratori
sampl
februari
februari
due
annual
review
dedic
investig
updat
guidelin
case
definit
sari
evolv
studi
period
februari
globalsurveil
case
definit
sari
exist
definit
sari
adapt
protocol
rapid
respons
person
year
old
wherea
children
year
old
sari
definit
adapt
program
integr
manag
childhood
ill
march
global
standard
tool
influenza
surveil
develop
adopt
januari
surveil
case
definit
sari
implement
follow
acut
respiratori
infect
histori
fever
measur
fever
cough
onset
within
last
day
requir
hospit
enrol
form
use
collect
data
enrol
elig
patient
includ
patient
demograph
medic
histori
clinic
sign
symptom
comorbid
report
influenza
vaccin
statu
recent
travel
histori
treatment
clinic
cours
outcom
patient
incomplet
medic
record
exclud
nasopharyng
np
oropharyng
op
swab
detect
virus
blood
cultur
detect
bacteria
taken
elig
patient
admiss
use
oper
procedur
describ
specimen
taken
averag
day
ill
onset
rang
day
total
nucleic
acid
tna
extract
autom
kingfish
flex
magnet
particl
processor
thermo
scientif
waltham
usa
use
magmax
total
nucleic
acid
isol
kit
cat
appli
biosystem
foster
ca
usa
accord
manufactur
instruct
viral
target
amplifi
use
specif
primer
probe
produc
cdc
atlanta
ga
usa
follow
standard
protocol
revers
transcript
polymeras
chain
reaction
detect
test
rsv
adenoviru
human
parainfluenza
virus
hpiv
influenza
b
human
metapneumoviru
conduct
cuh
laboratori
sent
confirm
naval
medic
research
unit
laboratori
test
conduct
cuh
laboratori
sampl
human
rnase
p
gene
rp
test
intern
posit
control
ensur
proper
sampl
collect
nucleic
acid
extract
sampl
consid
posit
viral
target
amplif
curv
cross
threshold
line
cycl
clinic
sampl
posit
rp
cutoff
valu
prescrib
previous
blood
sampl
collect
detect
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
use
rtqpcr
prior
studi
initi
studi
protocol
review
approv
institut
review
board
well
ethic
committe
cuh
complianc
applic
feder
us
regul
govern
protect
human
subject
inform
written
consent
obtain
patient
case
adult
patient
patient
parentleg
guardian
case
pediatr
patient
data
analys
conduct
use
softwar
spss
statist
packag
social
scienc
ibm
corp
ny
usa
version
data
summar
use
median
rang
quantit
variabl
number
percent
qualit
variabl
comparison
group
done
use
chisquar
test
qualit
variabl
independ
sampl
ttest
normal
distribut
quantit
variabl
mannwhitney
u
test
use
quantit
variabl
normal
distribut
indic
sever
diseas
assess
pathogen
interest
use
mantelhaenszel
estim
calcul
odd
ratio
confid
interv
mantelhaenszel
chisquar
test
assess
statist
signific
logist
regress
use
examin
associ
viral
respiratori
pathogen
sever
outcom
defin
ill
requir
ventil
intens
care
unit
icu
result
death
control
demograph
clinic
characterist
variabl
statist
signific
univari
associ
sever
outcom
includ
multivari
regress
analysi
test
twosid
differ
p
consid
signific
particip
enrol
sari
surveil
posit
result
viral
atyp
bacteria
test
includ
femal
male
median
age
one
year
rang
year
children
less
year
higher
viral
etiolog
patient
compar
one
adult
notabl
children
year
repres
patient
highest
rate
viral
infect
report
rsv
patient
piv
adenoviru
encount
virus
includ
rhinoviru
hmpv
boca
viru
respect
case
posit
mycoplasma
coinfect
rsv
one
case
chlamydia
coinfect
rsv
hmpv
neither
coronaviru
legionella
detect
tabl
show
data
comparison
nonvir
infect
individu
viralinfect
sari
one
significantli
predomin
sign
symptom
present
particularli
signific
viral
prodrom
symptom
well
tachypnea
wheez
convuls
among
individu
viral
pathogen
sari
patient
influenza
signific
tachypnea
p
wheez
abnorm
breath
sound
p
noninfluenza
viral
infect
patient
whose
specimen
collect
within
day
onset
symptom
like
viral
pathogen
detect
whose
specimen
collect
later
versu
p
fiftythre
percent
patient
least
one
underli
medic
condit
comorbid
includ
chronic
respiratori
disord
asthma
copd
bronchiectasi
immotil
cilia
syndrom
cardiac
disord
heart
failur
congenit
heart
diseas
cardiomyopathi
neuromuscular
disord
epilepsi
cerebr
palsi
myopathi
hematolog
disord
thalassemia
endocrin
disord
diabet
mellitu
hypothyroid
morbid
obes
renal
disord
endstag
renal
diseas
liver
disord
liver
cirrhosi
hepat
failur
patient
comorbid
n
significantli
older
compar
comorbid
median
age
versu
p
addit
significantli
like
symptomat
term
comorbid
patient
without
viral
detect
differ
significantli
frequenc
chronic
respiratori
endocrin
hepat
neuromuscular
disord
among
individu
viral
pathogen
sari
patient
parainfluenza
viru
signific
endocrin
p
neuromuscular
disord
nonparainfluenza
viral
infect
influenza
vaccin
histori
case
receiv
vaccin
within
month
prior
hospit
admiss
report
unknown
influenza
vaccin
statu
tabl
detail
result
comparison
nonvir
infect
individu
viralinfect
sari
one
significantli
lower
rate
pneumonia
admiss
icu
patient
influenza
viru
tend
significantli
differ
rate
admiss
icu
mechan
ventil
comparison
noninfluenza
infect
regard
complic
viralinfect
sari
patient
signific
differ
develop
respiratori
failur
acut
respiratori
distress
syndrom
ard
comparison
without
viral
infect
overal
mortal
sariposit
patient
peak
overal
adult
children
among
children
age
year
overal
twothird
comorbid
patient
die
admit
icu
mechan
ventil
notabl
patient
die
test
posit
viral
pathogen
twelv
posit
rsv
four
influenza
viru
two
adenoviru
one
hmpv
one
piv
four
mix
viral
infect
respect
among
die
signific
differ
without
viral
detect
p
among
individu
viral
pathogen
sari
patient
rsv
influenza
signific
death
p
comparison
nonrsv
noninfluenza
viral
infect
mortal
report
patient
atyp
bacteria
tabl
infect
independ
associ
increas
sever
sari
indic
ill
requir
mechan
ventil
andor
icu
andor
result
death
strong
evid
individu
rsv
influenza
less
like
experi
sever
outcom
infect
pathogen
rsv
ci
influenza
ci
individu
multipl
infect
like
infect
singl
pathogen
experi
sever
outcom
ci
p
sign
symptom
present
short
breath
endocrin
diseas
diabet
mellitu
logist
regress
use
examin
associ
sever
outcom
sariposit
individu
complet
demograph
data
clinic
risk
factor
univari
analysi
individu
posit
result
rhinoviru
adult
year
like
experi
sever
outcom
infect
rhinoviru
ci
children
year
ci
respect
multivari
analysi
confirm
result
individu
posit
result
rhinoviru
adult
year
like
experi
sever
tabl
show
result
commonli
detect
viru
among
cohort
clinic
characterist
outcom
rsvposit
patient
compar
respiratori
posit
case
well
viralneg
patient
patient
rsvposit
infect
signific
differ
respiratori
virus
identifi
regard
clinic
sign
symptom
comorbid
outcom
icu
admiss
death
differ
test
posit
viral
pathogen
regard
paramet
tabl
show
detail
logist
regress
use
examin
associ
sever
outcom
rsvposit
patient
complet
demograph
data
clinic
risk
factor
univari
analysi
individu
rsv
associ
comorbid
like
experi
sever
outcom
ci
rsv
comorbid
tabl
best
knowledg
largest
surveil
egyptian
studi
address
epidemiolog
pattern
sari
due
virus
atyp
bacteria
children
adult
popul
relat
clinic
characterist
outcom
patient
worldwid
distribut
viral
etiolog
caus
sari
vari
studi
found
viral
etiolog
hospit
patient
sari
compar
previou
studi
conduct
either
develop
middl
eastern
countri
find
twothird
sari
case
pathogen
detect
suggest
poor
late
specimen
collect
may
contribut
lower
yield
detect
virus
interestingli
children
year
repres
major
cohort
notabl
contradict
find
observ
studi
surveil
sari
northern
vietnam
nguyen
et
al
observ
cohort
children
year
adult
year
children
year
repres
case
accord
surveil
data
southern
arizona
lower
china
month
higher
highest
rate
viral
infect
report
rsv
piv
adenoviru
rel
low
rate
influenza
virus
unexpect
rsv
predomin
respiratori
viru
preval
emphas
role
major
caus
sari
infant
young
children
worldwid
notabl
proport
sari
case
posit
rsv
children
year
surveil
markedli
higher
report
surveil
data
kenya
southern
arizona
even
higher
previou
studi
egypt
observ
sari
case
year
significantli
like
older
patient
infect
pathogen
examin
particularli
rsv
influenza
major
enrol
patient
children
unexpect
sinc
pathogen
strong
associ
age
group
inconsist
data
nearli
children
expos
rsv
age
two
hmpv
age
five
hpiv
age
five
furthermor
hpiv
signific
etiolog
lrti
children
second
rsv
adenovirus
second
notabl
result
show
minor
role
atyp
bacteria
caus
sari
local
case
posit
mycoplasma
coinfect
rsv
one
case
chlamydia
coinfect
rsv
hmpv
clinic
present
differ
significantli
nonvir
infect
individu
viralinfect
sari
one
later
signific
viral
prodrom
symptom
well
tachypnea
wheez
convuls
furthermor
sari
patient
influenza
signific
tachypnea
wheez
abnorm
breath
sound
noninfluenza
viral
infect
presenc
sign
present
could
help
clinician
predict
like
pathogen
caus
sari
fiftythre
percent
patient
medic
comorbid
predomin
chronic
lung
diseas
impact
medic
comorbid
patient
sari
address
previou
surveil
studi
despit
cohort
children
less
year
patient
comorbid
significantli
older
compar
comorbid
patient
without
viral
detect
differ
significantli
frequenc
chronic
respiratori
well
endocrin
hepat
neuromuscular
disord
compar
clinic
cours
complic
outcom
viralinfect
case
nonvir
detect
control
show
interest
result
patient
identifi
virus
significantli
lower
rate
icu
admiss
hospit
stay
length
mechan
ventil
overal
mortal
without
identifi
virus
howev
differ
regard
ard
mechan
ventil
previou
studi
show
conflict
result
impact
viral
infect
clinic
outcom
patient
sari
differ
patient
number
enrol
criteria
methodolog
could
explain
result
although
pcr
establish
reliabl
diagnost
assay
high
sensit
specif
respiratori
virus
particularli
rsv
clinic
implic
posit
laboratori
result
still
less
clear
patient
posit
viral
detect
better
clinic
outcom
viral
detect
term
pneumonia
icu
admiss
overal
mortal
furthermor
compar
patient
viru
identifi
patient
rsvposit
infect
significantli
less
like
pneumonia
admit
icu
mechan
ventil
less
mortal
interestingli
analys
assess
associ
sever
outcom
current
studi
reveal
infect
independ
associ
outcom
even
control
age
associ
medic
comorbid
despit
predomin
rsv
infect
among
sariposit
case
strong
evid
individu
rsv
influenza
less
like
experi
sever
outcom
infect
pathogen
furthermor
individu
multipl
infect
like
infect
singl
pathogen
experi
sever
outcom
multivari
logist
regress
analysi
confirm
individu
posit
result
rhinoviru
adult
year
like
experi
sever
outcom
infect
rhinoviru
children
year
respect
howev
low
preval
rhinoviru
adult
studi
larger
studi
need
confirm
associ
commonli
detect
viru
among
cohort
interest
examin
rsvposit
case
interestingli
patient
rsvposit
infect
signific
differ
respiratori
virus
identifi
regard
clinic
sign
symptom
comorbid
outcom
differ
test
posit
viral
pathogen
regard
paramet
howev
individu
rsv
associ
medic
comorbid
like
experi
sever
outcom
rsv
comorbid
control
age
risk
factor
review
literatur
shown
conflict
result
clinic
implic
rsv
infect
relationship
rsv
infect
clinic
diseas
establish
infect
among
asymptomat
individu
rare
relationship
viral
load
diseas
sever
identifi
other
noninfluenza
virus
clinic
featur
still
unclear
adenoviru
infect
level
asymptomat
children
adult
vari
though
may
attribut
differ
sampl
methodolog
sinc
throat
swab
may
detect
latent
adv
dna
tonsil
tissu
studi
suggest
asymptomat
infect
hmpv
rare
among
children
result
adult
popul
less
conclus
report
vari
level
infect
among
asymptomat
individu
furthermor
clinic
implic
posit
laboratori
result
complic
presenc
coinfect
multipl
viral
respiratori
pathogen
identifi
case
coinfect
viral
respiratori
pathogen
encount
previou
report
among
pediatr
popul
middl
east
multipl
infect
complic
diagnosi
rel
clinic
impact
pathogen
unclear
certain
pathogen
adenoviru
routin
found
upper
airway
studi
mani
point
strength
first
surveil
address
clinic
impact
epidemiolog
pattern
viral
atyp
bacteria
caus
sari
children
adult
egyptian
popul
enrol
larg
number
patient
rel
long
period
furthermor
analys
homogen
popul
rather
differ
ethnic
group
give
result
reliabl
strong
support
hand
limit
time
may
need
properli
evalu
role
atyp
bacteria
flu
vaccin
use
current
studi
show
viral
pathogen
encount
onethird
hospit
adult
pediatr
egyptian
patient
sari
atyp
bacteria
minor
role
sari
local
highest
rate
viral
infect
report
rsv
piv
adenoviru
presenc
chronic
respiratori
endocrin
hepat
neuromuscular
disord
neg
affect
patient
identifi
viral
infect
viral
infect
neg
impact
clinic
featur
clinic
cours
sever
outcom
sari
local
studi
warrant
